CN1326854C - 取代的氨基－呋喃－2－基乙酸和氨基－噻吩－2－基－乙酸的衍生物及其在治疗偏头痛和疼痛中的应用 - Google Patents

取代的氨基－呋喃－2－基乙酸和氨基－噻吩－2－基－乙酸的衍生物及其在治疗偏头痛和疼痛中的应用 Download PDF

Info

Publication number
CN1326854C
CN1326854C CNB018197876A CN01819787A CN1326854C CN 1326854 C CN1326854 C CN 1326854C CN B018197876 A CNB018197876 A CN B018197876A CN 01819787 A CN01819787 A CN 01819787A CN 1326854 C CN1326854 C CN 1326854C
Authority
CN
China
Prior art keywords
methyl
furans
phenyl
chloro
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018197876A
Other languages
English (en)
Chinese (zh)
Other versions
CN1478089A (zh
Inventor
C·毛尔
W·恩格尔伯格
M·普尔策沃斯尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CN1478089A publication Critical patent/CN1478089A/zh
Application granted granted Critical
Publication of CN1326854C publication Critical patent/CN1326854C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB018197876A 2000-11-30 2001-11-28 取代的氨基－呋喃－2－基乙酸和氨基－噻吩－2－基－乙酸的衍生物及其在治疗偏头痛和疼痛中的应用 Expired - Fee Related CN1326854C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10059864.1 2000-11-30
DE10059864A DE10059864A1 (de) 2000-11-30 2000-11-30 Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate

Publications (2)

Publication Number Publication Date
CN1478089A CN1478089A (zh) 2004-02-25
CN1326854C true CN1326854C (zh) 2007-07-18

Family

ID=7665508

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018197876A Expired - Fee Related CN1326854C (zh) 2000-11-30 2001-11-28 取代的氨基－呋喃－2－基乙酸和氨基－噻吩－2－基－乙酸的衍生物及其在治疗偏头痛和疼痛中的应用

Country Status (29)

Country Link
US (1) US6797712B2 (https=)
EP (1) EP1341786B9 (https=)
JP (1) JP4340063B2 (https=)
KR (1) KR20030055334A (https=)
CN (1) CN1326854C (https=)
AR (1) AR035658A1 (https=)
AT (1) ATE418552T1 (https=)
AU (2) AU2073502A (https=)
BR (1) BR0115883A (https=)
CA (1) CA2430280A1 (https=)
CY (1) CY1108871T1 (https=)
CZ (1) CZ20031509A3 (https=)
DE (2) DE10059864A1 (https=)
DK (1) DK1341786T3 (https=)
EC (1) ECSDI034631S (https=)
ES (1) ES2320198T3 (https=)
HU (1) HUP0303041A3 (https=)
IL (2) IL156139A0 (https=)
MX (1) MXPA03004303A (https=)
NO (1) NO20032340L (https=)
NZ (1) NZ526554A (https=)
PE (1) PE20020599A1 (https=)
PL (1) PL362978A1 (https=)
PT (1) PT1341786E (https=)
RU (1) RU2003117703A (https=)
SI (1) SI1341786T1 (https=)
SK (1) SK5942003A3 (https=)
WO (1) WO2002044171A1 (https=)
ZA (1) ZA200305009B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
DE10125145A1 (de) 2001-05-22 2002-11-28 Gruenenthal Gmbh Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
DE10306203A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
DE10306202A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2008009079A2 (en) * 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
US9259426B2 (en) 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2016141092A1 (en) 2015-03-04 2016-09-09 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
EP3507288B1 (en) 2016-09-02 2020-08-26 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
CN109923106B (zh) 2016-09-02 2022-09-13 吉利德科学公司 toll样受体调节剂化合物
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
CN115382297B (zh) * 2022-04-12 2023-10-31 江阴市华思诚无纺布有限公司 熔体直纺双组分pet纺粘液体过滤材料及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000398A1 (en) * 1996-06-28 1998-01-08 University Of Southern California Method for the synthesis of amines and amino acids with organoboron derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441237B1 (en) 1999-02-20 2002-08-27 Boehringer Ingelheim Pharma Kg Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines
DE19907385A1 (de) * 1999-02-20 2000-08-24 Boehringer Ingelheim Pharma Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000398A1 (en) * 1996-06-28 1998-01-08 University Of Southern California Method for the synthesis of amines and amino acids with organoboron derivatives

Also Published As

Publication number Publication date
NZ526554A (en) 2005-02-25
KR20030055334A (ko) 2003-07-02
EP1341786B1 (de) 2008-12-24
US20040030156A1 (en) 2004-02-12
ECSDI034631S (https=) 2003-07-25
US6797712B2 (en) 2004-09-28
EP1341786A1 (de) 2003-09-10
EP1341786B9 (de) 2009-08-05
AR035658A1 (es) 2004-06-23
WO2002044171A1 (de) 2002-06-06
DE10059864A1 (de) 2002-06-13
PE20020599A1 (es) 2002-08-10
DE50114605D1 (de) 2009-02-05
IL156139A0 (en) 2003-12-23
NO20032340L (no) 2003-07-21
ES2320198T3 (es) 2009-05-20
RU2003117703A (ru) 2004-12-10
ZA200305009B (en) 2004-08-18
HUP0303041A2 (hu) 2003-12-29
ATE418552T1 (de) 2009-01-15
CZ20031509A3 (cs) 2003-09-17
AU2002220735B2 (en) 2007-05-10
HUP0303041A3 (en) 2007-06-28
PT1341786E (pt) 2009-03-31
CA2430280A1 (en) 2002-06-06
JP2004526675A (ja) 2004-09-02
DK1341786T3 (da) 2009-04-20
AU2073502A (en) 2002-06-11
IL156139A (en) 2007-08-19
CY1108871T1 (el) 2014-07-02
PL362978A1 (en) 2004-11-02
JP4340063B2 (ja) 2009-10-07
SK5942003A3 (en) 2003-11-04
SI1341786T1 (sl) 2009-04-30
CN1478089A (zh) 2004-02-25
BR0115883A (pt) 2003-12-02
HK1059080A1 (en) 2004-06-18
MXPA03004303A (es) 2003-08-19
NO20032340D0 (no) 2003-05-23

Similar Documents

Publication Publication Date Title
CN1326854C (zh) 取代的氨基－呋喃－2－基乙酸和氨基－噻吩－2－基－乙酸的衍生物及其在治疗偏头痛和疼痛中的应用
US8536221B2 (en) Amide derivatives as positive allosteric modulators and methods of use thereof
EP1401434B1 (en) Modulators of peroxisome proliferator activated receptors (ppar)
US7098241B2 (en) Thiophene hydroxamic acid derivatives
JP4993407B2 (ja) トリアゾール誘導体
EP1425010B1 (en) Substituted indoles and their use as integrin antagonists
KR101769654B1 (ko) 치환 아미드 화합물
TW201522303A (zh) 用於治療眼科疾病及病症之經取代３－苯基丙基胺衍生物
US9409864B2 (en) Sulfonamide TRPA1 receptor antagonists
US20120252853A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
TW201522288A (zh) α－取代甘胺醯胺衍生物
WO2021113808A1 (en) Cftr-modulating arylamides
WO2018161476A1 (zh) 一种酰胺类化合物及其制备方法和用途
JP6595509B2 (ja) Ｎ−スルホニルホモセリンラクトン誘導体、その調製方法及び使用
JP5776695B2 (ja) 置換アミド化合物
HK1059080B (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HK1059619B (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
HK1059619A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
JP2000026464A (ja) 芳香族複素環により構成されるチオカルバミン酸エステル誘導体
JP2006273847A (ja) シンナモイル化合物及びその用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070718

Termination date: 20091228